| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 31-Dec-08 | | Total Revenue | 6,205,000 | 6,125,000 | 5,884,000 | 6,086,000 | | Cost of Revenue | 4,894,000 | 4,839,000 | 4,697,000 | 4,910,000 | | | Gross Profit | 1,311,000 | 1,286,000 | 1,187,000 | 1,176,000 | | | Operating Expenses | | Research Development | 407,000 | (111,000) | 111,000 | 138,000 | | Selling General and Administrative | 139,000 | 632,000 | 364,000 | 392,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 765,000 | 765,000 | 712,000 | 646,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 14,000 | 16,000 | (1,000) | (4,000) | | Earnings Before Interest And Taxes | 779,000 | 781,000 | 711,000 | 642,000 | | Interest Expense | 32,000 | 31,000 | 32,000 | 32,000 | | Income Before Tax | 747,000 | 750,000 | 679,000 | 610,000 | | Income Tax Expense | 248,000 | 246,000 | 222,000 | 189,000 | | Minority Interest | 20,000 | (20,000) |
-
|
-
| | | | Net Income From Continuing Ops | 519,000 | 484,000 | 457,000 | 421,000 | | | Non-recurring Events | | Discontinued Operations | (1,000) | (3,000) | 3,000 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 518,000 | 481,000 | 460,000 | 421,000 | | Preferred Stock And Other Adjustments | (28,000) | 8,000 | (8,000) |
-
| | | Net Income Applicable To Common Shares | $490,000 | $489,000 | $452,000 | $421,000 |
|
0.16% Nasdaq 
0.21 (0.41%) 
Income Statement
